Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29365143 | 1.00 | ERN1 (0.59) | ERN1MAPTMEN1KMT2AALOX15 | |
| SCHEMBL26345927 | 0.94 | ERN1 (0.54) | ERN1MAPTMEN1KMT2AALOX15 | |
| SCHEMBL26205109 | 0.92 | ERN1 (0.56) | ERN1MAPTMEN1KMT2AALOX15 | |
| SCHEMBL8653093 | 0.91 | POLB (0.53) | ERN1MAPTMEN1KMT2ACYP1A2 | |
| SCHEMBL5620225 | 0.91 | POLB (0.53) | ERN1MAPTMEN1KMT2ACYP1A2 | |
| SCHEMBL24891578 | 0.88 | ERN1 (0.53) | ERN1MAPTMEN1KMT2AALOX15 | |
| SCHEMBL18529230 | 0.85 | ESR1 (0.64) | ERN1MAPTMEN1KMT2AKDM4E | |
| SCHEMBL25953081 | 0.85 | ERN1 (0.50) | ERN1MAPTMEN1KMT2AALOX15 | |
| SCHEMBL12949860 | 0.85 | ERN1 (0.46) | ERN1MAPTMEN1KMT2AALOX15 | |
| SCHEMBL19712934 | 0.85 | ERN1 (0.46) | ERN1MAPTMEN1KMT2AALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040785-A | Metal organic framework composite material with circularly polarized room temperature phosphorescence characteristic and preparation method thereof | 南京工业大学 | 2025-05-27 | — | — | CN | claimed |
| CN-118878923-A | Modified calcium carbonate applied to flame-retardant polypropylene filling and preparation method thereof | 江苏恒凌奇科技有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-113999089-B | Method for synthesizing 6,6 '-dibromo-1, 1' -bi-2-naphthol by oxidative coupling of 6-bromo-2-naphthol | 中唯炼焦技术国家工程研究中心有限责任公司 | 2024-05-14 | — | — | CN | claimed |
| CN-112920813-B | Photo-thermal response chiral photosensitive liquid crystal dopant containing azobenzene binaphthyl | 湘潭大学 | 2023-08-22 | — | — | CN | claimed |
| CN-111519275-B | Sheath-core structure composite fiber and nonwoven fabric comprising same | 天津工业大学 | 2022-07-08 | — | — | CN | claimed |
| CN-113999089-A | Method for synthesizing 6,6 '-dibromo-1, 1' -bi-2-naphthol by oxidative coupling of 6-bromo-2-naphthol | 中唯炼焦技术国家工程研究中心有限责任公司 | 2022-02-01 | — | — | CN | claimed |
| CN-112409136-A | Method for preparing 6,6 ' -dibromo-1, 1 ' -binaphthyl-2, 2 ' -diphenol by efficient clean bromination | 中唯炼焦技术国家工程研究中心有限责任公司 | 2021-02-26 | — | — | CN | claimed |
| US-8084611-B2 | Process for preparing tetrahydroquinoline derivatives | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2011-12-27 | — | — | US | claimed |
| EP-2004622-B1 | CHIRAL BINAPHTHYL SULFATES FOR USE AS LIQUID CRYSTAL MATERIALS | MERCK PATENT GMBH (DE) | 2011-12-14 | — | — | EP | claimed |
| US-7943061-B2 | Chiral binaphthyl sulfates for use as liquid crystal materials | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-05-17 | — | — | US | claimed |
| US-20080281108-A1 | Chiral Compounds | MERCK PATENT GMBH (DE) | 2008-11-13 | — | — | US | claimed |
| EP-1928854-A1 | CHIRAL COMPOUNDS | Merck Patent GmbH (DE) | 2008-06-11 | — | — | EP | claimed |
| WO-2007124383-A2 | 1,1'-BINAPHTHYL-BASED INHIBITORS OF NAD+-DEPENDENT DEACETYLASE ACTIVITY AND SIR2-FAMILY MEMBERS | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2007-11-01 | — | — | WO | claimed |
| WO-2007116922-A1 | A PROCESS FOR PREPARING TETRAHYDROQUINOLINE DERIVATIVES | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-10-18 | — | — | WO | claimed |
| WO-2007039105-A1 | CHIRAL COMPOUNDS | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | WO | claimed |
| US-6384228-B2 | EPIBATIDINE; ANALGESICS; ANIMAL EXTRACTS | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2002-05-07 | — | — | US | claimed |
| US-6339159-B1 | REACTING AN ALDEHYDE COMPOUND, AN AMINO COMPOUND AND HYDROGEN CYANATE IN THE PRESENCE OF A CHIRAL ZIRCONIUM CATALYST OBTAINED BY MIXING ZIRCONIUM ALKOXIDE WITH OPTICALLY ACTIVE BINAPHTHOL COMPOUND TO FORM ALPHA-AMINONITRILE | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2002-01-15 | — | — | US | claimed |
| EP-0764878-B1 | Photothermographic elements comprising hydroxamic acid developers | IMATION CORP (US) | 2000-05-24 | — | — | EP | claimed |
| EP-0471498-B1 | Optical resolution method | KANKYO KAGAKU CENTER (JP) | 1997-12-17 | — | — | EP | claimed |
| EP-0764878-A1 | Photothermographic elements comprising hydroxamic acid developers | Imation Corp. (US) | 1997-03-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080281108-A1 | Chiral Compounds | LAGE3, DDT, CUTA | ERN1 3021/4885MAPT 2299/4885MEN1 350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.